In this section, we provide a brief overview of HuR’s emerging roles in extrahepatic metabolic diseases commonly associated with MASLD, highlighting its potential contribution to the broader metabolic syndrome context. This evidence concerns the gene ELAVL1 and Other metabolic disease.